[PDF][PDF] Estimating the effectiveness of Tdap vaccine for preventing pertussis: evidence of rapidly waning immunity and differences in effectiveness by Tdap brand
R Koepke, JC Eickhoff, RA Ayele, AB Petit, SL Schauer… - J Infect Dis, 2014 - Citeseer
Background: We estimated tetanus-diphtheria-acellular pertussis (Tdap) vaccine
effectiveness (VE) for preventing pertussis among adolescents during a statewide outbreak …
effectiveness (VE) for preventing pertussis among adolescents during a statewide outbreak …
Reduced-Antigen, Combined Diphtheria-Tetanus-Acellular Pertussis Vaccine, Adsorbed (Boostrix® US Formulation) Use as a Single-Dose Booster Immunization in …
JE Frampton, SJ Keam - Pediatric Drugs, 2006 - Springer
Abstract▲ Boostrix® US formulation (hereafter referred to as Tdap) is a formulation of
reduced-antigen, combined diphtheria-tetanus-acellular pertussis vaccine, adsorbed onto …
reduced-antigen, combined diphtheria-tetanus-acellular pertussis vaccine, adsorbed onto …
Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus …
R Dominicus, F Galtier, P Richard, M Baudin - Vaccine, 2014 - Elsevier
Introduction The immunogenicity and safety of one dose of Tdap-IPV (tetanus, diphtheria,
acellular pertussis and inactivated poliomyelitis vaccine) and two doses of Td-IPV (tetanus …
acellular pertussis and inactivated poliomyelitis vaccine) and two doses of Td-IPV (tetanus …
Phase 1 trial of an investigational Tdap booster vaccine with CpG 1018 adjuvant compared with Boostrix in healthy adults and adolescents
P Richmond, T Nolan, A McGirr, F Napier-Flood, J Kim… - Vaccine, 2024 - Elsevier
This phase 1 trial assessed the safety and immunogenicity of an investigational
tetanus/diphtheria/acellular pertussis vaccine combined with CpG 1018 adjuvant 1500 μg …
tetanus/diphtheria/acellular pertussis vaccine combined with CpG 1018 adjuvant 1500 μg …
Randomized study of immune responses to two Tdap vaccines among adolescents primed with DTaP and comparison with results among adolescents primed with …
MD Decker, DP Greenberg, DR Johnson, V Pool - Vaccine, 2019 - Elsevier
Background It has been reported that persons primed with acellular (DTaP) pertussis
vaccines have reduced duration of pertussis protection compared with those primed with …
vaccines have reduced duration of pertussis protection compared with those primed with …
Booster vaccination of toddlers with reduced antigen content diphtheria–tetanus–acellular pertussis vaccine
Immunogenicity and reactogenicity of DTPa and reduced antigen dTpa booster vaccines
were compared to a hepatitis A control vaccine in DTPa-primed toddlers aged 18–20 …
were compared to a hepatitis A control vaccine in DTPa-primed toddlers aged 18–20 …
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) …
B Thierry-Carstensen, K Jordan, HH Uhlving, T Dalby… - Vaccine, 2012 - Elsevier
BACKGROUND: Increasing incidence of pertussis in adolescents and adults has stimulated
the development of safe and immunogenic acellular pertussis vaccines for booster …
the development of safe and immunogenic acellular pertussis vaccines for booster …
[HTML][HTML] Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria–tetanus–acellular pertussis and …
M Kovac, N Rathi, S Kuriyakose, K Hardt, TF Schwarz - Vaccine, 2015 - Elsevier
Background Pertussis in adults and adolescents could be reduced by replacing traditional
tetanus and diphtheria (Td) boosters with reduced-antigen-content diphtheria–tetanus …
tetanus and diphtheria (Td) boosters with reduced-antigen-content diphtheria–tetanus …
Booster vaccination against pertussis in Chinese children at six years of age using reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (Boostrix™ …
F Zhu, S Zhang, Q Hou, Y Zhang, Y Xu, X Ma… - Human …, 2010 - Taylor & Francis
Pertussis continues to circulate in Chinese communities and older children, adolescents and
adults are sources of infection for unprotected infants. Two studies conducted in Jiangsu …
adults are sources of infection for unprotected infants. Two studies conducted in Jiangsu …
Safety and immunogenicity of tetanus-diphtheria-acellular pertussis vaccine administered to children 10 or 11 years of age
GS Marshall, V Pool, DP Greenberg… - Clinical and Vaccine …, 2014 - Am Soc Microbiol
Boosting immunity to tetanus, diphtheria, and pertussis through the use of Tdap vaccines is
routinely recommended at 11 to 12 years of age; some states, however, require Tdap for …
routinely recommended at 11 to 12 years of age; some states, however, require Tdap for …